C4 Therapeutics Inc.
04/14/2025 | Press release | Distributed by Public on 04/14/2025 06:17
Management Change/Compensation (Form 8-K)
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Departure of Director
On April 10, 2025, Bruce Downey notified the Board of Directors (the "Board") of C4 Therapeutics, Inc. (the "Company") of his intention to retire from the Board and not to stand for reelection at the 2025 Annual Meeting of Stockholders. Mr. Downey's decision not to stand for reelection was not due to any disagreements with the Company on any matter relating to the Company's strategy, operations, policies or practices. Following the Company's 2025 Annual Meeting of Stockholders, Mr. Downey will cease to serve as director, as well as chair and a member of the Organization, Leadership and Compensation Committee, member of the Audit Committee, and a member of the Nominating and Corporate Governance Committee